31 filings
8-K
EIDX
Eidos Therapeutics, Inc.
26 Jan 21
Entry into a Material Definitive Agreement
8:46am
8-K
EIDX
Eidos Therapeutics, Inc.
20 Jan 21
Submission of Matters to a Vote of Security Holders
4:23pm
8-K
EIDX
Eidos Therapeutics, Inc.
12 Jan 21
Other Events
7:31am
8-K
EIDX
Eidos Therapeutics, Inc.
29 Oct 20
Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business Update
4:30pm
8-K
EIDX
Eidos Therapeutics, Inc.
6 Oct 20
Entry into a Material Definitive Agreement
9:35pm
8-K
j8csektm 069d
5 Oct 20
Bridgebio Pharma and Eidos Therapeutics Announce Merger Agreement
4:06pm
8-K
7xbiob8k
29 Sep 20
Regulation FD Disclosure
7:15am
8-K
4recf8f5x5nhxg o3g
7 Aug 20
Eidos Therapeutics Appoints Industry Leaders With Significant Development and Commercial Expertise to Board of Directors
4:56pm
8-K
92rt8zwsqmyniegq kau
6 Aug 20
Eidos Therapeutics Reports Second Quarter 2020 Financial Results and Business Update
4:33pm
8-K
ccworkt9rd1b9
1 Jun 20
Departure of Directors or Certain Officers
4:05pm
8-K
7heed2rfafif
8 May 20
Eidos Therapeutics Reports First Quarter 2020 Financial Results and Business Update
4:30pm
8-K
rvifyaw5nxuf3
24 Mar 20
Other Events
6:06am
8-K
x6ife
26 Feb 20
Eidos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Business Update
4:30pm
8-K
b86wssvil
7 Jan 20
Departure of Directors or Certain Officers
4:48pm
8-K
zlhzyv5
17 Dec 19
Departure of Directors or Certain Officers
4:03pm
8-K
qg0iph0
18 Nov 19
Entry into a Material Definitive Agreement
8:01am
8-K
qwvn7w574
31 Oct 19
Eidos Therapeutics Reports Third Quarter 2019 Financial Results and Business Update
4:30pm
8-K
8dslmjva om8
13 Sep 19
Eidos Therapeutics Special Committee Rejects Proposal from BridgeBio Pharma to Acquire Shares
4:05pm
8-K
2kjs5n9
11 Sep 19
Entry into a Material Definitive Agreement
4:36pm
8-K
p88 4i7dw4o3mrltfahw
12 Aug 19
Eidos Therapeutics Confirms Receipt ofNon-Binding Proposal from BridgeBio Pharma to Acquire Shares
4:27pm